Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

29 Jan 2018 16:10

On the 23 rd January, Michael Barnard ( director ) purchased 3240 shares in New Century Aim VCT2 at a price of 61p, taking his holding up to 430,718 shares equivalent to 9.35% of the issued ordinary share capital.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180129005796/en/

Copyright Business Wire 2018

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.